Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
To enhance technological efficiency, improve data analytics, and address medical needs, leading hospitals in both the US and Europe are currently utilizing Aurora to oversee every facet of patient IVF cycles and conduct research on Cardiomyopathy patients. The landscape of medicine, along with the understanding of diseases and the decisions required, is poised for transformation. Our software is adaptable, designed to facilitate prompt modifications tailored to the unique requirements and procedural standards of your organization. A comprehensive view of patient data is essential for making informed treatment choices. This encompasses phenotype and genotype information, laboratory test results, family medical histories, pedigrees, and narrative reports. All clinical information is systematically gathered, analyzed, and displayed in a cohesive package. Clinicians have the capability to search and access data through various methods, including a complete overview of longitudinal studies. Additionally, our products are crafted by a collaboration of software engineers and data professionals who partner closely with clinicians across different specialties to ensure that the tools meet practical needs. By integrating these elements, we strive to empower healthcare providers with the insights necessary for optimal patient care.
Description
Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Boston Advanced Analytics
Country
United States
Website
www.bostonadvancedanalytics.com/technology-emr-software/aurora/
Vendor Details
Company Name
IPM.ai
Country
United States
Website
www.ipm.ai/platform
Product Features
Electronic Medical Records (EMR)
Appointment Management
Charting
Compliance Tracking
E-Prescribing
E/M Coding
HIPAA Compliant
Handwriting Recognition
Integrated Telehealth
MIPS Certified
Meaningful Use Certified
ONC-ATCB Certified
Patient Portal
Self Service Portal
Voice Recognition